Endoscopically removed rectal NETs: a nationwide cohort study
Authors:
- 23 November 2020
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 36 (3) , 535-541
Abstract
Purpose Rectal neuroendocrine tumours (NETs) often present as an incidental finding during colonoscopy. Complete endoscopic resection of low-grade NETs up to 10 mm is considered safe. Whether this is also safe for NETs up to 20 mm is unclear. We performed a nationwide study to determine the risk of lymph node and distant metastases in endoscopically removed NETs. Methods All endoscopically removed rectal NETs between 1990 and 2010 were identified using the national pathology database (PALGA). Each NET was stratified according to size, grade and resection margin. Follow-up was until February 2016. Results Between 1990 and 2010, a total of 310 NETs smaller than 20 mm were endoscopically removed. Mean size of NETs was 7.4 mm (SD 3.5). In 49% of NETs (n = 153), no grade (G) could be assessed from the pathology report, 1% was G2 (n = 3), and the remaining NETs were G1. Median follow up was 11.6 years (range 4.9–26.0). During follow-up, 30 patients underwent surgical resection. Lymph node or distant metastasis was seen in 3 patients (1%) which all had a grade 2 NET. Mean time from endoscopic resection to diagnosis of metastases was 6.1 years (95% CI 2.9–9.2). Conclusion No lymph node or distant metastases were seen in endoscopically removed G1 NETs up to 20 mm during the long follow-up of this nationwide study. This adds evidence to the ENET guideline that endoscopic resection of G1 NETs up to 20 mm appears to be safe.Keywords
Funding Information
- Maag Lever Darm Stichting (I 16-13)
This publication has 26 references indexed in Scilit:
- Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decadeUnited European Gastroenterology Journal, 2020
- ENETS Consensus Guidelines Update for Colorectal Neuroendocrine NeoplasmsNeuroendocrinology, 2016
- Neuroendocrine Tumors, Version 1.2015Journal of the National Comprehensive Cancer Network, 2015
- Risk Factors Associated with Rectal Neuroendocrine Tumors: A Cross-Sectional StudyCancer Epidemiology, Biomarkers & Prevention, 2014
- Endoscopically identified well-differentiated rectal carcinoid tumors: impact of tumor size on the natural history and outcomesGastrointestinal Endoscopy, 2014
- Tu1163 Macroscopic Features of Neuroendocrine Colorectal Cancers: A 10-Year Retrospective StudyGastroenterology, 2012
- Trends of Incidence and Survival of Gastrointestinal Neuroendocrine Tumors in the United States: A Seer AnalysisJournal of Cancer, 2012
- The NANETS Consensus Guidelines for the Diagnosis and Management of Gastrointestinal Neuroendocrine Tumors (NETs)Pancreas, 2010
- Rectal carcinoids are on the rise: early detection by screening endoscopyEndoscopy, 2009
- A 5‐decade analysis of 13,715 carcinoid tumorsCancer, 2003